Microvascular basal lamina damage in thromboembolic stroke in a rat model

Neurosci Lett. 2003 Dec 26;353(3):217-20. doi: 10.1016/j.neulet.2003.09.050.

Abstract

We investigated microvascular damage in areas with magnetic resonance imaging (MRI)-defined apparent diffusion coefficient reduction (ADC-R) in a rat model of thromboembolic occlusion of the middle cerebral artery. Rats received either intracarotid recombinant tissue plasminogen activator (rt-PA) or saline. Microvascular basal lamina damage was quantified by immunohistochemical staining of collagen type IV and by videoimaging analysis. ADC-R positive basal ganglia (cortical) areas showed a significant reduction of stained microvascular area by 15+/-6% (8+/-7%) and the microvascular density by 13+/-5% (8+/-6%) of that on the non-ischemic control side (P<0.001). There were no significant microvascular differences between rats given rt-PA or saline, or between those with or without angiographically proven recanalization. This study reports for the first time that microvascular basal lamina damage in experimental thromboembolic stroke is confined to regions with ADC-R in MRI.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiography / methods
  • Animals
  • Basal Ganglia / metabolism
  • Basal Ganglia / pathology
  • Basement Membrane / pathology*
  • Cerebellar Cortex / metabolism
  • Cerebellar Cortex / pathology
  • Collagen Type II / metabolism
  • Disease Models, Animal
  • Immunohistochemistry / methods
  • Infarction, Middle Cerebral Artery / complications
  • Magnetic Resonance Imaging / methods
  • Rats
  • Rats, Sprague-Dawley
  • Stroke / etiology
  • Stroke / pathology*
  • Thromboembolism / etiology
  • Thromboembolism / pathology*
  • Tissue Plasminogen Activator / therapeutic use

Substances

  • Collagen Type II
  • Tissue Plasminogen Activator